Barclays Reiterates Buy Rating on RXO, Inc.
Barclays maintains its buy rating for RXO, Inc. with a $28 price target, a 1.49% upside from the current price.
Key Points
- Barclays reiterated its buy rating on RXO, Inc. (NYSE:RXO) with a price target of $28 on June 26, 2026.
- Barclays's $28 price target implies 1.49% upside from RXO, Inc.'s ($RXO) current $27.59 share price.
- RXO shares traded at approximately $26.90, with a market cap of about $4.47 billion and a forward P/E ratio of 54.1.
- Insiders, including CEO Andrew Wilkerson, have been active in trading RXO shares, and analysts maintain varied ratings.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Barclays has reiterated its buy rating for RXO, Inc. (NYSE:RXO), setting a price target of $28. This update came from analyst Brandon Oglenski on June 26, 2026. Shares of RXO traded around $26.90 on Saturday.
Barclays vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in RXO, Inc.
Several institutional investors have made moves in RXO, Inc. ORBIS Allan Gray Ltd increased its holdings by 1,720,219 shares, bringing its total to 36,397,974 shares valued at about $532.1 million. MFN Partners Management, LP added 532,276 shares, ending with 28,109,942 shares worth approximately $411 million. BlackRock, Inc. also boosted its stake by 267,801 shares, now holding 24,165,879 shares valued at $353.3 million. Finepoint Capital LP grew its position by 684,829 shares to 10,073,618 shares, valued at $147.3 million. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, with share counts of 9,034,799 and 7,370,484, respectively.
RXO, Inc. Stock Up 25.9%
On Saturday, RXO, Inc. shares traded near $26.90. The company holds a market capitalization of about $4.47 billion and a forward P/E ratio of 54.1. RXO's beta is 1.968, indicating higher volatility compared to the market. The stock's 52-week range spans from $10.43 to $29.86, with a 50-day moving average of $23.13 and a 200-day average of $16.99. RXO has a current ratio of 1.274 and a quick ratio of 1.18, with a debt-to-equity ratio of 46.32.
$RXO price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
RXO, Inc. posted revenue of approximately $5.73 billion, though it experienced a slight revenue decline of 0.6%. The company recorded a net margin of -1.83% and a return on equity of -6.78%. RXO's next earnings report is expected on August 6, 2026.
Insider Buying and Selling at RXO, Inc.
CEO Andrew Wilkerson has been active with RXO stock, making multiple transactions. On May 15, 2026, he both bought and sold 168,943 shares. Earlier, on May 2, 2026, Wilkerson sold 40,370 shares at an average price of $19.59. Additionally, Chief Accounting Officer Daniel Morris purchased 13,377 shares on May 15, 2026.
Analysts Set New Price Targets
Barclays maintained its buy rating for RXO, Inc. with a $28 target on June 26, 2026. Stifel upgraded the stock to a buy with a $22 target on May 15, 2026. UBS and Citigroup both maintained hold ratings with $22 and $24 targets, respectively, on May 8, 2026. Truist Securities also maintained a buy rating with a $26 target. The consensus among analysts is a hold, with an average price target of $22.07 based on 15 opinions.
About RXO, Inc.
RXO, Inc. operates in the trucking industry, offering truckload freight brokering services across the United States, Canada, Mexico, Asia, and Europe. The company provides asset-light managed transportation and last-mile services, along with freight forwarding, ocean and air transportation, and customs brokerage. Headquartered in Charlotte, North Carolina, RXO was incorporated in 2022 and is led by CEO Drew M. Wilkerson. The company employs approximately 6,906 people.
Bottom Line
Barclays' reiteration of a buy rating for RXO, Inc. reflects continued confidence in the company's prospects, with a price target of $28. Investors follow these ratings closely as they can influence market perceptions and stock performance. It's important to remember that analyst ratings are based on past data and market conditions, and they may not predict future outcomes.
Get RXO, Inc. alerts
New 13F filings, insider trades, and analyst moves on $RXO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.